Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

60 Degrees Pharmaceuticals (SXTP) Current Leases (2022 - 2023)

60 Degrees Pharmaceuticals (SXTP) has disclosed Current Leases for 2 consecutive years, with $13650.0 as the latest value for Q4 2023.

  • On a quarterly basis, Current Leases rose 5.0% to $13650.0 in Q4 2023 year-over-year; TTM through Dec 2023 was $13650.0, a 5.0% increase, with the full-year FY2023 number at $13650.0, up 5.0% from a year prior.
  • Current Leases was $13650.0 for Q4 2023 at 60 Degrees Pharmaceuticals, down from $26800.0 in the prior quarter.
  • In the past five years, Current Leases ranged from a high of $39470.0 in Q2 2023 to a low of $13000.0 in Q4 2022.